Your browser doesn't support javascript.
loading
Clinical Phage Microbiology: a suggested framework and recommendations for the in-vitro matching steps of phage therapy.
Gelman, Daniel; Yerushalmy, Ortal; Alkalay-Oren, Sivan; Rakov, Chani; Ben-Porat, Shira; Khalifa, Leron; Adler, Karen; Abdalrhman, Mohanad; Coppenhagen-Glazer, Shunit; Aslam, Saima; Schooley, Robert T; Nir-Paz, Ran; Hazan, Ronen.
Affiliation
  • Gelman D; Institute of Biomedical and Oral Research, Faculty of Dental Medicine, Hebrew University of Jerusalem, Jerusalem, Israel; Department of Military Medicine, Hebrew University of Jerusalem, Jerusalem, Israel; Department of Clinical Microbiology and Infectious Diseases, Hadassah-Hebrew University Medica
  • Yerushalmy O; Institute of Biomedical and Oral Research, Faculty of Dental Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.
  • Alkalay-Oren S; Institute of Biomedical and Oral Research, Faculty of Dental Medicine, Hebrew University of Jerusalem, Jerusalem, Israel; Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel; Department of Clinical Microbiology and Infectious Diseases, Hadassah-Hebrew University Medical Center, Je
  • Rakov C; Institute of Biomedical and Oral Research, Faculty of Dental Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.
  • Ben-Porat S; Institute of Biomedical and Oral Research, Faculty of Dental Medicine, Hebrew University of Jerusalem, Jerusalem, Israel; Department of Military Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.
  • Khalifa L; Institute of Biomedical and Oral Research, Faculty of Dental Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.
  • Adler K; Institute of Biomedical and Oral Research, Faculty of Dental Medicine, Hebrew University of Jerusalem, Jerusalem, Israel; Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel; Department of Clinical Microbiology and Infectious Diseases, Hadassah-Hebrew University Medical Center, Je
  • Abdalrhman M; Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel; Department of Clinical Microbiology and Infectious Diseases, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.
  • Coppenhagen-Glazer S; Institute of Biomedical and Oral Research, Faculty of Dental Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.
  • Aslam S; Division of Infectious Diseases and Global Health, University of California, San Diego, CA, USA; Center for Innovative Phage Applications and Therapeutics, University of California, San Diego, CA, USA.
  • Schooley RT; Center for Innovative Phage Applications and Therapeutics, University of California, San Diego, CA, USA; Department of Medicine, University of California, San Diego, CA, USA.
  • Nir-Paz R; Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel; Department of Clinical Microbiology and Infectious Diseases, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.
  • Hazan R; Institute of Biomedical and Oral Research, Faculty of Dental Medicine, Hebrew University of Jerusalem, Jerusalem, Israel. Electronic address: ronenh@ekmd.huji.ac.il.
Lancet Microbe ; 2(10): e555-e563, 2021 10.
Article in En | MEDLINE | ID: mdl-35544180
ABSTRACT
Phage therapy is a promising solution for bacterial infections that are not eradicated by conventional antibiotics. A crucial element of this approach is appropriate matching of bacteriophages and antibiotics to the bacterial target according to the clinical setting. However, there is currently little consistency in the protocols used for the laboratory evaluation of bacteriophages intended for antibacterial treatment. In this Personal View, we suggest a framework aimed to match appropriate bacteriophage-based treatments in clinical microbiology laboratories. This framework, which we have termed Clinical Phage Microbiology, is based on the current research on phage treatments. In addition, we discuss special cases that might require additional relevant evaluation, including bacteriophage interactions with the host immune response, biofilm-associated infections, and polymicrobial infections. The Clinical Phage Microbiology pipeline could serve as the basis for future standardisation of laboratory protocols for personalised phage therapy.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Bacterial Infections / Bacteriophages / Phage Therapy Type of study: Guideline Limits: Humans Language: En Journal: Lancet Microbe Year: 2021 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Bacterial Infections / Bacteriophages / Phage Therapy Type of study: Guideline Limits: Humans Language: En Journal: Lancet Microbe Year: 2021 Document type: Article
...